Menu
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Context
An American biopharmaceutical company asked Vivactis Market Access for services related to market access consulting for its portfolio to contribute to its goals of serving the community as well as contribute to grow its business in the Benelux.
Objective
Vivactis Market Access’s objective for this market access consultancy was centered on three key projects:
1. Support the market access activities with
• an audit
• a gap analysis with a “CAPA”-equivalent
• prepare possible economic inspections
2. Compile and submit pricing and reimbursement files for selected products
3. Strategic consultancy about the best approach for Belgium, the Netherlands, and Luxembourg
Our approach
The methodology was based on:
• Deskwork
• Fieldwork with visits to key stakeholders
• Own resources, network and experience
Results
The biopharmaceutical company benefits from having a direct contact with our core of associates and from a productive collaboration with a select network of leading experts.
A situational analysis and strategy review report was delivered:
It describes the analyses of the available data and its environment in the Benelux in the context of the preparation of market access activities. In addition, it contains a strategic recommendation of action. The report starts with a brief overview of the healthcare systems. Next, it outlines the research findings and sets out the pricing and reimbursement process, and provides a detailed situation analysis. Finally, it concludes with specific recommendations for pricing and reimbursement submissions.